Results
|
2241.
|
|
|
2242.
|
|
|
2243.
|
The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients: An updated systematic review and meta-analysis. [electronic resource] by
- Shang, Heli
- Zhang, Zewen
- Feng, Alei
- Yang, Xiaowei
- Zhang, Shuisheng
- Zhao, Yi
- Zhu, Qingshan
- Mao, Yantao
- Liu, Kun
- Tian, Yuan
Producer: 20190813
In:
Medicine vol. 98
Availability: No items available.
|
|
2244.
|
|
|
2245.
|
|
|
2246.
|
|
|
2247.
|
|
|
2248.
|
|
|
2249.
|
Angiotensin II contributes to intratumoral immunosuppressionvia induction of PD-L1 expression in non-small cell lung carcinoma. [electronic resource] by
- Yang, Kaiyong
- Zhou, Jiaqian
- Chen, Yan
- Chen, Yan
- Chen, Lili
- Zhang, Pei
- Ma, Lin
- Jiang, Zhengyu
- Bian, Jinjun
- Yin, Wu
Producer: 20210310
In:
International immunopharmacology vol. 84
Availability: No items available.
|
|
2250.
|
|
|
2251.
|
|
|
2252.
|
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma. [electronic resource] by
- Faraj, Sheila F
- Munari, Enrico
- Guner, Gunes
- Taube, Janis
- Anders, Robert
- Hicks, Jessica
- Meeker, Alan
- Schoenberg, Mark
- Bivalacqua, Trinity
- Drake, Charles
- Netto, George J
Producer: 20150504
In:
Urology vol. 85
Availability: No items available.
|
|
2253.
|
|
|
2254.
|
|
|
2255.
|
|
|
2256.
|
|
|
2257.
|
|
|
2258.
|
|
|
2259.
|
|
|
2260.
|
|